R. H. Meyboom, M. Lindquist, and A. C. Egberts, An ABC of drug-related problems, Drug Saf, vol.22, pp.415-423, 2000.

, World Health Organization. The importance of pharmacovigilance-Safety monitoring of medicinal products. Geneva: World Health Organisation, 2002.

. Who-umc.-uppsala and . Reports, Antimicrobial resistance-An overlooked adverse event, vol.74, 2017.

, Promoting rational use of medicines: Core components-WHO, Policy Perspectives on Medicines, issue.5, 2002.

R. Ofori-asenso and A. Agyeman, Irrational Use of Medicines-A Summary of Key Concepts, Pharmacy, vol.4, p.35, 2016.

A. Hassan, G. A. Abdullahi, and A. A. Ahmed, Assessing prescriber's awareness of essential medicine list, hospital drug formulary and utilization of standard treatment guidelines in a tertiary healthcare facility in North-Central Nigeria, Alexandria J Med, vol.54, pp.81-84, 2018.

D. Lee and U. Bergman, Studies of Drug Utilization, pp.377-401, 2012.

, World Health Organisation. WHO drug use in health facilites, 1993.

A. O. Isah, J. Ohaju-obodo, and E. C. Isah, Drug use profile in a Nigerian city hospital, Pharmacoepidemiol Drug Saf, vol.6, pp.319-324, 1997.
DOI : 10.1002/(sici)1099-1557(199709/10)6:5<319::aid-pds307>3.0.co;2-u

E. T. Adebayo and N. A. Hussain, Pattern of prescription drug use in Nigerian army hospitals, Ann Afr Med, vol.9, pp.152-160, 2010.

A. Isah, R. Laing, and J. Quick, The Development of Reference Values for the WHO Health Facility Core Prescribing Indicators, West Afr J Pharmacol Drug Res, vol.18, pp.6-11, 2001.

O. A. Akoria and A. Isah, An evaluation of doctors' prescribing performance in Nigeria, Pakistan J Med Sci, vol.25, pp.533-538, 2009.

A. A. Desalegn, Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: a cross-sectional study, BMC Health Serv Res, vol.13, p.170, 2013.

R. I. Okoli, A. O. Isah, and R. I. Ozolua, Drug prescribing pattern in three levels of health care facilities in the north and central senatorial districts of Edo State, Nigeria, Int J Herbs Pharmacol Res, vol.4, pp.46-57, 2015.

R. Adisa, T. O. Fakeye, and A. Vo, Evaluation of prescription pattern and patients ' opinion on healthcare practices in selected primary healthcare facilities in Ibadan , South-Western Nigeria, Afri Heal Sci, vol.15, pp.1318-1329, 2015.

, WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2017.

, Federal Ministry of Health, Essential Medicines List, 2010.

M. Ibrahim, Physicians' prescribing behaviour in two tertiary health care facilities in north-western Nigeria --Analysis of 518 prescriptions, Sahel Med J, vol.7, pp.115-118, 2004.

A. O. Jimoh, I. Omar, and I. M. Adebisi, Review of Morbidity Profiles and Drug Prescribing Patterns of a University Clinic in North-Western Nigeria, Int J Med Med Sci, vol.1, pp.107-115, 2014.

E. Enato and I. E. Chima, Evaluation of drug utilization patterns and patient care practices, West African J Pharm, vol.22, pp.36-41, 2011.

M. Sisay, G. Mengistu, and B. Molla, Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: a cross sectional study, BMC Health Serv Res, vol.17, p.161, 2017.

U. Ijoma, I. Onwuekwe, and O. Onodugo, Effect of promotional strategies of pharmaceutical companies on doctors

K. Turk-silahl, Koruyucu Hekim Bul, vol.9, pp.1-6, 2010.

G. P. Velo and P. Minuz, Medication errors: prescribing faults and prescription errors, Br J Clin Pharmacol, vol.67, pp.624-628, 2009.
DOI : 10.1111/j.1365-2125.2009.03425.x

URL : https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2125.2009.03425.x

I. Tamuno and J. O. Fadare, Drug prescription pattern in a Nigerian Tertiary hospital, Trop J Pharm Res, vol.11, pp.146-152, 2012.

N. Henry, C. Ogaji, J. Ikoni, and S. , Drug Use pattern with standard indicators in Jos University Hospital Nigeria, West African J Pharm, vol.24, pp.88-93, 2013.

A. Ragam, S. Acharya, and R. Holla, Assessment of drug use pattern using World Health Organization prescribing indicators in a tertiary care hospital in Mangalore: A crosssectional study, Natl J Physiol Pharm Pharmacol, vol.7, p.1, 2017.

M. B. Maiyaki and M. A. Garbati, The burden of non-communicable diseases in Nigeria; in the context of globalization, Ann Afr Med, vol.13, pp.1-10, 2014.

, Federal Ministry of Health. National antimalarial treatment policy, 2005.

O. A. Akoria and A. Olowofela, Impact of an educational intervention on the prescribing of antimalarials at the University of Benin Teaching Hospital, Int J Heal Res, vol.4, pp.117-122, 2011.

P. Maryah, B. Denue, and N. Ikunaiye, Evaluation of antimalarial drugs usage according to WHO prescribing indicators in a tertiary health facility in Maiduguri, Northeastern Nigeria, Port Harcourt Med J, vol.11, p.67, 2017.

, Federal Republic of Nigeria. National Drug Formulary and Essential drug list act, vol.43, 1989.

M. Atif, S. Scahill, and M. Azeem, Drug utilization patterns in the global context: A systematic review, Heal Policy Technol, vol.6, pp.457-470, 2017.

S. E. Gulmez, D. Larrey, and G. Pageaux, Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen), Drug Saf, vol.36, pp.135-144, 2013.
DOI : 10.1007/s40264-012-0013-7

URL : https://link.springer.com/content/pdf/10.1007%2Fs40264-012-0013-7.pdf

, World Health Organization. The Importance of Pharmacovigilance, Safety Monitoring of Medicinal Products. Geneva: World Health Organisation, 2002.

R. H. Meyboom, A. C. Egberts, and F. W. Gribnau, Pharmacovigilance in perspective, Drug Saf, vol.21, pp.429-447, 1999.

. Who-umc.-uppsala and . Reports, Antimicrobial resistance-An overlooked adverse event, vol.74, 2017.

, World Health Organization-Uppsala Monitoring Centre. Uppsala reports, 2014.

L. Hazell and S. Shakir, Under-Reporting of Adverse Drug Reactions, Drug Saf, vol.29, pp.385-396, 2006.

Y. Moride, F. Haramburu, and A. A. Requejo, Under-reporting of adverse drug reactions in general practice, Br J Clin Pharmacol, vol.43, pp.177-81, 1997.

E. Lopez-gonzalez, M. Herdeiro, and A. Figueiras, Determinants of Under-reporting of adverse drug reactions-A systematic review, Drug Saf, vol.32, pp.19-31, 2009.

A. Olowofela, A. Fourrier-réglat, and A. O. Isah, Pharmacovigilance in Nigeria: An Overview, Pharmaceut Med, vol.30, pp.87-94, 2016.
DOI : 10.1007/s40290-015-0133-3

O. O. Enwere and O. Fawole, Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf, vol.17, pp.517-539, 2008.

K. A. Oshikoya and J. O. Awobusuyi, Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in, BMC Clin Pharmacol, vol.9, p.14, 2009.

J. O. Fadare, O. O. Enwere, and A. O. Afolabi, Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria, Trop J Pharm Res, vol.10, pp.235-242, 2011.

S. O. Bello and M. T. Umar, Knowledge and attitudes of physicians relating to reporting of adverse drug reactions in Sokoto, north-western Nigeria, Ann Afr Med, vol.10, pp.13-21, 2011.

S. Ogundele, C. Dawodu, and O. Ogunleye, Adverse drug reaction reporting among healthcare workers at a Nigerian Tertiary Hospital: a comparative cross-sectional survey of health care professionals, Glob Res J Med Sci, vol.2, pp.32-37, 2012.

J. U. Chinenye and O. U. Michael, Health workers and hospital patients knowledge of Pharmacovigilance in Sokoto, Niger J Pharm Sci, vol.11, pp.31-40, 2012.

, National Pharmacovigilance Centre (NPC) NAFDAC. Safety of medicines in Nigeria: a guide for detecting and reporting adverse drug reactions. NAFDAC-NPC-NIG, 2004.

J. Bland, B. Butland, and J. Peacock, Sample size calculation, Statistical Guide for Research Grant Application, pp.37-44, 2012.

A. Figueiras, M. T. Herdeiro, and J. Polónia, An educational intervention to improve physician reporting of adverse drug reactions: A cluster-randomized controlled trial, JAMA, vol.296, pp.1086-1093, 2006.

E. Ekman and M. Bäckström, Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden, Eur J Clin Pharmacol, vol.65, pp.43-46, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00477927

I. A. Eland, K. J. Belton, and A. C. Van-grootheest, Attitudinal survey of voluntary reporting of adverse drug reactions, Br J Clin Pharmacol, vol.48, pp.623-630, 1999.

K. J. Belton, S. C. Lewis, and S. Payne, Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom, Br J Clin Pharmacol, vol.39, pp.223-229, 1995.

M. Kharkar, S. Bowalekar, and . Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting

, Perspect Clin Res, vol.3, p.90, 2012.

R. C. Okechukwu, S. O. Odinduka, G. N. Ele1, and M. J. Okonta, Awareness, Attitude, and Practice of Pharmacovigilance among Health Care Professionals in Nigeria: Survey in a Teaching Hospital, Int J Hosp Res, vol.3, pp.99-108, 2013.

A. Y. Ezeuko, U. E. Ebenebe, and C. C. Nnebue, Adverse Drug Reaction reporting by different categories of healthcare workers in Nnewi, Nigeria: awareness, knowledge and attitudes, Br J Med Med Res, vol.7, pp.932-941, 2015.

S. Olsson, S. N. Pal, and A. Stergachis, Pharmacovigilance activities in 55 low-and middle-income countries: A questionnaire-based analysis, Drug Saf, vol.33, pp.689-703, 2010.

A. O. Isah, S. N. Pal, and S. Olsson, Specific features of medicines safety and pharmacovigilance in Africa, Ther Adv Drug Saf, vol.3, pp.25-34, 2012.

B. Katusiime, D. Semakula, and S. J. Lubinga, Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda, Afr Health Sci, vol.15, pp.1308-1317, 2015.

A. Saleh, H. Figueras, A. Fourrier-réglat, and A. Knowledge, Attitude and Practice of Health Professionals Towards Adverse Drug Reactions Reporting, Eur J Pharm Med Res, vol.3, pp.12-21, 2016.

N. Vargesson, Thalidomide-induced teratogenesis: History and mechanisms, Birth Defects Res Part C Embryo Today Rev, vol.105, pp.140-156, 2015.

R. Kiguba, C. Karamagi, and P. Waako, Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants, BMJ Open, vol.4, p.5869, 2014.

A. Bénard-laribière, G. Miremont-salamé, and M. Pérault-pochat, Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study, Fundam Clin Pharmacol, vol.29, pp.106-111, 2015.

H. Khalili, N. Mohebbi, and N. Hendoiee, Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre-and post-clinical pharmacists' interventional study, BMJ Open, vol.2, pp.367-000367, 2012.

A. Saleh, H. Figueras, and A. , Fourrier-Réglat A. Knowledge, attitude and practice of health professionals towards adverse drug reactions reporting, Eur J Pharm Med Res, vol.3, pp.12-21, 2016.

C. Gonzalez-gonzalez, E. Lopez-gonzalez, and M. T. Herdeiro, References 1. World Health Organization. The importance of pharmacovigilance-Safety monitoring of medicinal products, Geneva: World Health Organisation, vol.36, pp.317-328, 2002.

A. Saleh, H. Figueras, and A. , Fourrier-Réglat A. Knowledge, attitude and practice of health professionals towards adverse drug reactions reporting, Eur J Pharm Med Res, vol.3, pp.12-21, 2016.

A. O. Isah, S. N. Pal, and S. Olsson, Specific features of medicines safety and pharmacovigilance in Africa, Ther Adv Drug Saf, vol.3, pp.25-34, 2012.

, Federal Ministry of Health. National drug policy, 2005.

, Federal Ministry of Health. Nigerian National pharmacovigilance policy and implementation framework, 2012.

, National Pharmacovigilance Centre (NPC) NAFDAC. Introducing the PVG/FDIC newsletter, Pharmacovigilance/FDIC newsletter, vol.I, pp.42-43, 2007.

A. Olowofela, A. Fourrier-réglat, and A. O. Isah, Pharmacovigilance in Nigeria: An Overview, Pharmaceut Med, vol.30, pp.87-94, 2016.
DOI : 10.1007/s40290-015-0133-3

J. O. Fadare, O. O. Enwere, and A. O. Afolabi, Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria, Trop J Pharm Res, vol.10, pp.235-242, 2011.

S. Ogundele, C. Dawodu, and O. Ogunleye, Adverse drug reaction reporting among healthcare workers at a Nigerian Tertiary Hospital: a comparative cross-sectional survey of health care professionals, Glob Res J Med Sci, vol.2, pp.32-37, 2012.

R. C. Okechukwu, S. O. Odinduka, and G. N. Ele, Awareness, Attitude, and Practice of Pharmacovigilance among Health Care Professionals in Nigeria: Survey in a Teaching Hospital, Int J Hosp Res, vol.3, pp.99-108, 2013.

, National Agency for Food and Drug Administration And Control{NAFDAC}. Safety of medicines in Nigeria: a guide for detecting and reporting adverse drug reactions, NAFDAC-NPC-NIG, 2004.

G. J. Dal-pan, Ongoing Challenges in Pharmacovigilance, Drug Saf, vol.37, pp.1-8, 2014.

A. Osakwe, I. Oreagba, and A. J. Adewunmi, Impact of training on Nigerian healthcare professionals' knowledge and practice of pharmacovigilance, Int J Risk Saf Med, vol.25, pp.219-227, 2013.

N. Jha, D. Singh-rathore, and P. R. Shankar, An educational intervention's effect on healthcare professionals' attitudes towards pharmacovigilance, Australas Med J, vol.7, pp.478-489, 2014.
DOI : 10.4066/amj.2014.2235

URL : https://doi.org/10.4066/amj.2014.2235

S. Patel, C. K. Desai, and R. K. Dikshit, An impact of educational interventions on reporting of adverse drug reactions, Int J Pharm, vol.5, pp.485-492, 2015.

S. Ganesan, S. Sandhiya, and K. C. Reddy, The impact of the educational intervention on knowledge, attitude, and practice of pharmacovigilance toward adverse drug reactions reporting among Health-care Professionals in a tertiary care hospital in South India, J Nat Sci Biol Med, vol.8, pp.203-209, 2017.

F. R. Varallo, C. S. Planeta, and C. Mastroianni-p-de, Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff, Clinics (Sao Paulo), vol.72, pp.51-57, 2017.

M. Eccles, J. Grimshaw, and M. Campbell, Research designs for studies evaluating the effectiveness of change and improvement strategies, Qual Saf Heal Care, vol.12, pp.47-52, 2003.

K. A. Kannisto, M. H. Koivunen, and M. A. Välimäki, Use of mobile phone text message reminders in health care services: a narrative literature review, J Med Internet Res, vol.16, p.222, 2014.

M. C. Gulliford, O. Ukoumunne, and S. Chinn, Methods for Evaluating Organisationor Area-Based Health Interventions, The Advanced Handbook of Methods in Evidence Based Healthcare, pp.295-313, 2001.

P. G. Smith, R. Morrow, and D. Ross, Field Trials of Health Interventions: A Toolbox, 2015.

A. Figueiras, M. T. Herdeiro, and J. Polónia, An educational intervention to improve physician reporting of adverse drug reactions: A cluster-randomized controlled trial, JAMA, vol.296, pp.1086-1093, 2006.

D. Davis, M. O&apos;brien, and N. Freemantle, Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?, JAMA, vol.282, pp.867-874, 1999.

, International drug monitoring: the role of national centres, 1972.

I. R. Edwards and J. K. Aronson, Adverse drug reactions: definitions, diagnosis, and management, Lancet, vol.356, pp.1255-1264, 2000.

R. H. Meyboom, Y. A. Hekster, and A. C. Egberts, Causal or casual? The role of causality assessment in pharmacovigilance, Drug Saf, vol.17, pp.374-89, 1997.

M. Kharkar, S. Bowalekar, and . Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting

, Perspect Clin Res, vol.3, pp.90-94, 2012.

K. A. Oshikoya and J. O. Awobusuyi, Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in, BMC Clin Pharmacol, vol.9, p.14, 2009.

E. Lopez-gonzalez, M. Herdeiro, and A. Figueiras, Determinants of Under-reporting of adverse drug reactions-A systematic review, Drug Saf, vol.32, pp.19-31, 2009.

S. O. Bello and M. T. Umar, Knowledge and attitudes of physicians relating to reporting of adverse drug reactions in Sokoto, north-western Nigeria, Ann Afr Med, vol.10, pp.13-21, 2011.

E. Ekman and M. Bäckström, Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden, Eur J Clin Pharmacol, vol.65, pp.43-46, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00477927

I. A. Eland, K. J. Belton, and A. C. Van-grootheest, Attitudinal survey of voluntary reporting of adverse drug reactions, Br J Clin Pharmacol, vol.48, pp.623-630, 1999.

K. J. Belton, S. C. Lewis, and S. Payne, Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom, Br J Clin Pharmacol, vol.39, pp.223-229, 1995.

J. U. Chinenye and O. U. Michael, Health workers and hospital patients knowledge of Pharmacovigilance in Sokoto, Niger J Pharm Sci, vol.11, pp.31-40, 2012.

, Centers for Disease Control and Prevention and US Department of Health and Human Services. CDC -Epi Info TM, vol.7, issue.6, 2008.

E. Lopez-gonzalez, M. T. Herdeiro, and M. Piñeiro-lamas, Effect of An Educational Intervention to Improve Adverse Drug Reaction Reporting in Physicians: A Cluster Randomized Controlled Trial, Drug Saf, vol.38, pp.189-196, 2014.

C. Pagotto, F. Varallo, and P. Mastroianni, Impact of Educational Interventions on Adverse Drug Events Reporting, Int J Technol Assess Health Care, vol.29, pp.410-417, 2013.

R. Kiguba, C. Karamagi, and P. Waako, Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants, BMJ Open, vol.4, p.5869, 2014.

A. Farha, R. , A. Hammour, K. Rizik, and M. , Effect of educational intervention on healthcare providers knowledge and perception towards pharmacovigilance: A tertiary teaching hospital experience, Saudi Pharm J, vol.26, pp.611-616, 2018.

A. S. Bhagavathula, A. A. Elnour, and S. Q. Jamshed, Health Professionals' Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta-Analysis, PLoS One, vol.11, p.152221, 2016.

O. O. Ogunleye, I. A. Oreagba, and C. Falade, Medication errors among health professionals in Nigeria: A national survey, Int J Risk Saf Med, vol.28, pp.77-91, 2016.

V. Kalaiselvan, P. Thota, and G. N. Singh, Pharmacovigilance Programme of India: Recent developments and future perspectives, Indian J Pharmacol, vol.48, pp.624-628, 2016.

S. Shamim, S. M. Sharib, and S. M. Malhi, Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists, Springerplus, vol.5, p.1778, 2016.

F. M. Alsaleh, S. W. Alzaid, and E. A. Abahussain, Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait, Saudi Pharm J, vol.25, pp.830-837, 2017.

P. Craig, P. Dieppe, and S. Macintyre, Developing and evaluating complex interventions: the new Medical Research Council guidance, BMJ, vol.337, p.1655, 2008.

G. T. Sabblah, P. Akweongo, and D. Darko, Adverse drug reaction reporting by doctors in a developing country: a case study from Ghana, Ghana Med J, vol.48, pp.189-93, 2014.

I. Ribeiro-vaz, C. C. Santos, and R. Cruz-correia, Promoting adverse drug reaction reporting: comparison of different approaches, Rev Saude Publica, vol.50, p.14, 2016.

S. Olsson, S. N. Pal, and A. Dodoo, Pharmacovigilance in resource-limited countries, Expert Rev Clin Pharmacol, vol.8, pp.449-460, 2015.

, World Health Organization. WHO pharmacovigilance indicators: A practical manual for the assessment of pharmacovigilance systems, Geneva: World Health Organisation, 2015.

B. R. Kirkwood, S. N. Cousens, and C. G. Victora, Issues in the design and interpretation of studies to evaluate the impact of community-based interventions, Trop Med Int Heal, vol.2, pp.1022-1029, 1997.

, References 1. WHO. International drug monitoring: the role of national centres, 1972.

M. Pirmohamed, S. James, and S. Meakin, Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients, BMJ, vol.329, pp.15-24, 2004.

J. Lazarou, B. H. Pomeranz, and P. N. Corey, Incidence of Adverse Drug Reactions in Hospitalized Patients, JAMA, vol.279, p.1200, 1998.

J. Sultana, P. Cutroneo, and G. Trifirò, Clinical and economic burden of adverse drug reactions, J Pharmacol Pharmacother, vol.4, pp.73-77, 2013.

A. Olowofela, A. Fourrier-réglat, and A. O. Isah, Pharmacovigilance in Nigeria: An Overview, Pharmaceut Med, vol.30, pp.87-94, 2016.

N. Moore, The past, present and perhaps future of pharmacovigilance: Homage to Folke Sjoqvist, Eur J Clin Pharmacol, vol.69, 2013.

, World Health Organization. Safety Monitoring of Medicinal Products: Guidelines for setting up and running a Pharmacovigilance Centre, 2000.

L. Hazell and S. Shakir, Under-Reporting of Adverse Drug Reactions, Drug Saf, vol.29, pp.385-396, 2006.

L. Aagard, J. Strandell, and L. Melskens, Global patterns of adverse drug reactions over a decade-Analyses of spontaneous reports to Vigibase, Drug Saf, vol.35, pp.1171-1182, 2012.

A. O. Isah, S. N. Pal, and S. Olsson, Specific features of medicines safety and pharmacovigilance in Africa, Ther Adv Drug Saf, vol.3, pp.25-34, 2012.

I. A. Oreagba, K. A. Oshikoya, and C. Ogar, Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from, Pharmacol Res Perspect, vol.5, p.297, 2004.

S. Ogundele, C. Dawodu, and O. Ogunleye, Adverse drug reaction reporting among healthcare workers at a Nigerian Tertiary Hospital: a comparative cross-sectional survey of health care professionals, Glob Res J Med Sci, vol.2, pp.32-37, 2012.

R. C. Okechukwu, S. O. Odinduka, and G. N. Ele, Awareness, Attitude, and Practice of Pharmacovigilance among Health Care Professionals in Nigeria: Survey in a Teaching Hospital, Int J Hosp Res, vol.3, pp.99-108, 2013.

A. Y. Ezeuko, U. E. Ebenebe, and C. C. Nnebue, Adverse Drug Reaction reporting by different categories of healthcare workers in Nnewi, Nigeria: awareness, knowledge and attitudes, Br J Med Med Res, vol.7, pp.932-941, 2015.

E. Lopez-gonzalez, M. Herdeiro, and A. Figueiras, Determinants of Under-reporting of adverse drug reactions-A systematic review, Drug Saf, vol.32, pp.19-31, 2009.

R. M. Akuse and F. F. Garnett, Spontaneous reporting of paediatric adverse drug reactions in a Nigerian tertiary health centre -any relationship to severity ?, Int J Pharm Sci Invent, vol.2, pp.5-11, 2013.

R. Aderemi-williams, O. Awodele, and C. Boyle, Adverse Drug Reactions Amongst Adult Patients Admitted in Lagos State University Teaching Hospital Lagos, Curr Drug Saf, vol.10, pp.136-144, 2015.

C. Gonzalez-gonzalez, E. Lopez-gonzalez, and M. T. Herdeiro, Strategies to Improve Adverse Drug Reaction Reporting: A Critical and Systematic Review, Drug Saf, vol.36, pp.317-328, 2013.

S. Patel, C. K. Desai, and R. K. Dikshit, An impact of educational interventions on reporting of adverse drug reactions, Int J Pharm, vol.5, pp.485-492, 2015.

A. Osakwe, I. Oreagba, and A. J. Adewunmi, Impact of training on Nigerian healthcare professionals' knowledge and practice of pharmacovigilance, Int J Risk Saf Med, vol.25, pp.219-227, 2013.

. Angelis-a-de, A. Giusti, and S. Colaceci, Nurses' reporting of suspect adverse drug reactions: a mixed-methods study, Ann Ist Super Sanita, vol.51, pp.277-283, 2015.

I. Ribeiro-vaz, C. C. Santos, and R. Cruz-correia, Promoting adverse drug reaction reporting: comparison of different approaches, Rev Saude Publica, vol.50, p.14, 2016.

F. R. Varallo, C. S. Planeta, and C. Mastroianni-p-de, Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff, Clinics (Sao Paulo), vol.72, pp.51-57, 2017.

M. Tabali, E. Jeschke, and A. Bockelbrink, Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine, BMC Public Health, vol.9, p.274, 2009.

P. G. Smith, R. Morrow, and D. Ross, Field Trials of Health Interventions: A Toolbox, 2015.

D. Davis, M. O&apos;brien, and N. Freemantle, Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?, JAMA, vol.282, pp.867-874, 1999.

A. Figueiras, M. T. Herdeiro, and J. Polónia, An educational intervention to improve physician reporting of adverse drug reactions: A cluster-randomized controlled trial, JAMA, vol.296, pp.1086-1093, 2006.

M. Eccles, J. Grimshaw, and M. Campbell, Research designs for studies evaluating the effectiveness of change and improvement strategies, Qual Saf Heal Care, vol.12, pp.47-52, 2003.

, World Health Organization. The importance of pharmacovigilance-Safety monitoring of medicinal products. Geneva: World Health Organisation, 2002.

, National Agency for Food and Drug Administration And Control{NAFDAC}. Safety of medicines in Nigeria: a guide for detecting and reporting adverse drug reactions, NAFDAC-NPC-NIG, 2004.

I. R. Edwards and J. K. Aronson, Adverse drug reactions: definitions, diagnosis, and management, Lancet, vol.356, pp.1255-1264, 2000.
DOI : 10.1016/s0140-6736(00)02799-9

R. H. Meyboom, Y. A. Hekster, and A. C. Egberts, Causal or casual? The role of causality assessment in pharmacovigilance, Drug Saf, vol.17, pp.374-89, 1997.

, Harmonised Tripartite Guideline: Clinical Safety Data Management: Definitions and Standards for Expedited Reporting E2a, 1994.

, WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2017.

. Who-umc, The use of the WHO-UMC system for standardised case causality assessment, 2012.

C. A. Naranjo, U. Busto, and E. M. Sellers, A method for estimating the probability of adverse drug reactions, Clin Pharmacol Ther, vol.30, pp.239-284, 1981.

M. Gony, K. Badie, and A. Sommet, Improving Adverse Drug Reaction Reporting in Hospitals, Drug Saf, vol.33, pp.409-416, 2010.

E. Lopez-gonzalez, M. T. Herdeiro, and M. Piñeiro-lamas, Effect of An Educational Intervention to Improve Adverse Drug Reaction Reporting in Physicians: A Cluster Randomized Controlled Trial, Drug Saf, vol.38, pp.189-196, 2015.

, Report from the WHO collaborating centre for International Drug Monitoring -Activities, 2004.

R. M. Martin, P. N. Biswas, and S. N. Freemantle, Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: Analysis of 48 cohort studies, Br J Clin Pharmacol, vol.46, pp.505-511, 1998.

F. T. Bourgeois, M. W. Shannon, and C. Valim, Adverse Drug Events in the Outpatient Setting: An 11-Yar National Analysis, Pharmacoepidemiol Drug Saf, vol.19, pp.901-910, 2011.

T. Oni and N. Unwin, Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: Implications of multimorbidity for health systems in an era of health transition, Int Health, vol.7, pp.390-399, 2015.

H. H. Ampadu, J. Hoekman, and M. L. De-bruin, Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®, Drug Saf, vol.39, pp.335-345, 2016.

D. F. Berhe, K. Juhlin, and K. Star, Adverse Drug Reaction reports for cardiometabolic drugs from sub-Saharan Africa: a study in VigiBase, Trop Med Int Heal, vol.20, pp.797-806, 2015.

A. Salami and I. Katibi, Angiotensin converting Enzyme Inhibitors associated cough a prospective evaluation in hypertensives, Ann Afr Med, vol.4, pp.118-121, 2005.

A. Olowofela and A. O. Isah, A profile of adverse effects of antihypertensive medicines in a tertiary care clinic in Nigeria, Ann Afr Med, vol.16, pp.114-119, 2017.

I. Tamuno and J. O. Fadare, Drug prescription pattern in a Nigerian Tertiary hospital, Trop J Pharm Res, vol.11, pp.146-152, 2012.

I. Chijioke-nwauche and J. Akodo, Evaluation of drug use pattern in Lulu Brigg's Health Centre, University of Port Harcourt, Nigeria using WHO prescribing indicators, The Pharmainnovation J, vol.6, pp.506-510, 2017.

L. Salm-reifferscheidt and . Tramadol, Africa's opioid crisis, Lancet, vol.391, pp.1982-1983, 2018.

, Restricting Use Of Codeine And Tramadol In Children, Recommending Against Use In Breastfeeding Women. News, 2017.

A. V. Marzano, A. Borghi, and M. Cugno, Adverse drug reactions and organ damage: The skin, Eur J Intern Med, vol.28, pp.17-24, 2016.

R. Okechukwu, S. Odinduka, and G. Ele, Awareness, attitude and practiceof pharmacovigilance among health care professionals in Nigeria: Survey in a Teaching Hospital, Int J Hosp Res, vol.2, pp.99-108, 2013.

F. M. Alsaleh, S. W. Alzaid, and E. A. Abahussain, Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait, Saudi Pharm J, vol.25, pp.830-837, 2017.

T. Bergvall, G. Niklas-norén, and M. Lindquist, VigiGrade: A tool to identify welldocumented individual case reports and highlight systematic data quality issues, Drug Saf, vol.37, pp.65-77, 2014.

M. Lindquist, Data Quality Management in Pharmacovigilance, Drug Saf, vol.27, pp.857-870, 2004.

B. Sánchez-sánchez, A. , M. Kravzov-jinich, and J. , Evaluation of Completeness of Suspected Adverse Drug Reaction Reports Submitted to the Mexican National Pharmacovigilance Centre, Drug Saf, vol.35, pp.837-844, 2012.

L. Plessis, A. Gómez, and N. García, Lack of essential information in spontaneous reports of adverse drug reactions in Catalonia-a restraint to the potentiality for signal detection, Eur J Clin Pharmacol, vol.73, pp.751-758, 2017.

N. Aminu, A. Sha&apos;aban, and A. Abubakar, Unveiling the peril of substandard and falsified medicines to public health and safety in Africa: Need for all-out war to end the menace, Med Access Point Care, vol.1, pp.1596-3519, 2017.

D. Akinyuli, Counterfeit and Sub-standard Drugs, Nigeria's Experience: Implications, Challenges, Actions and Recommendations, 2005.

, Federal Ministry of Health. National drug policy, 2005.

, Federal Ministry of Health. Nigerian National pharmacovigilance policy and implementation framework, 2012.

, Strengthening Pharmaceutical Systems (SPS) Program. Safety of Medicines in SubSaharan Africa: Assessment of Pharmacovigilance Systems and their Performance. Arlington VA: US Agency for International Development, 2011.

, Promoting rational use of medicines: Core components-WHO, Policy Perspectives on Medicines, issue.5, 2002.

A. O. Olowofela and A. O. Isah, Medication use practices and inspection of returned pills during follow-up attendance at a tertiary care hypertension clinic in Nigeria, Sahel Med J, vol.21, pp.128-164, 2018.

J. Sultana, P. Cutroneo, and G. Trifirò, Clinical and economic burden of adverse drug reactions, J Pharmacol Pharmacother, vol.4, pp.73-80, 2013.

, Nigeria hypertension Society Guidelines committee, 2005.

H. Hamishehkar, F. Ranjdoost, and P. Asgharian, Are They Safe?, Adv Pharm Bull, vol.6, pp.467-477, 2016.

A. Isah, R. Laing, and J. Quick, The Development of Reference Values for the WHO Health Facility Core Prescribing Indicators, West Afr J Pharmacol Drug Res, vol.18, pp.6-11, 2001.

, Federal Ministry of Health. National antimalarial treatment policy, 2005.

, Federal Ministry of Health. Standard Treatment Guideline, Federal Ministry of Health, 2008.

C. K. O&apos;neil, J. T. Hanlon, and Z. A. Marcum, Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics, Am J Geriatr Pharmacother, vol.10, pp.331-373, 2012.

S. E. Gulmez, D. Larrey, and G. Pageaux, Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen), Drug Saf, vol.36, pp.135-144, 2013.

L. Ibanez, X. Vidal, and L. Vendrell, Upper gastrointestinal bleeding associated with antiplatelet drugs, Aliment Pharmacol Ther, vol.23, pp.235-242, 2006.

M. Shamna, C. Dilip, and M. Ajmal, A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital, Saudi Pharm J, vol.22, pp.303-308, 2014.

O. O. Enwere and O. Fawole, Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf, vol.17, pp.517-539, 2008.

K. A. Oshikoya and J. O. Awobusuyi, Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in, BMC Clin Pharmacol, vol.9, p.14, 2009.

S. O. Bello and M. T. Umar, Knowledge and attitudes of physicians relating to reporting of adverse drug reactions in Sokoto, north-western Nigeria, Ann Afr Med, vol.10, pp.13-21, 2011.

J. O. Fadare, O. O. Enwere, and A. O. Afolabi, Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria, Trop J Pharm Res, vol.10, pp.235-242, 2011.

S. Ogundele, C. Dawodu, and O. Ogunleye, Adverse drug reaction reporting among healthcare workers at a Nigerian Tertiary Hospital: a comparative cross-sectional survey of health care professionals, Glob Res J Med Sci, vol.2, pp.32-37, 2012.

J. U. Chinenye and O. U. Michael, Health workers and hospital patients knowledge of Pharmacovigilance in Sokoto, Niger J Pharm Sci, vol.11, pp.31-40, 2012.

O. O. Ogunleye, I. A. Oreagba, and C. Falade, Medication errors among health professionals in Nigeria: A national survey, Int J Risk Saf Med, vol.28, pp.77-91, 2016.

K. J. Belton, S. C. Lewis, and S. Payne, Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom, Br J Clin Pharmacol, vol.39, pp.223-229, 1995.

K. C. Santosh, P. Tragulpiankit, and S. Gorsanan, Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal, BMC Pharmacol Toxicol, vol.14, p.16, 2013.

B. Katusiime, D. Semakula, and S. J. Lubinga, Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda

, Afr Health Sci, vol.15, pp.1308-1325, 2015.

E. Lopez-gonzalez, M. Herdeiro, and A. Figueiras, Determinants of Under-reporting of adverse drug reactions-A systematic review, Drug Saf, vol.32, pp.19-31, 2009.

S. Hanafi, H. Torkamandi, and A. Hayatshahi, An educational intervention to improve nurses' knowledge, attitude, and practice toward reporting of adverse drug reactions, Iran J Nurs Midwifery Res, vol.19, pp.1-6, 2014.

S. Alan, M. Ozturk, and S. Gokyildiz, An evaluation of knowledge of pharmacovigilance among nurses and midwives in Turkey, Indian J Pharmacol, vol.45, pp.616-618, 2013.

. Angelis-a-de, A. Giusti, and S. Colaceci, Nurses' reporting of suspect adverse drug reactions: a mixed-methods study, Ann Ist Super Sanita, vol.51, pp.277-283, 2015.

J. Beckmann, U. Hagemann, and P. Bahri, Teaching Pharmacovigilance: the WHOISoP Core Elements of a Comprehensive Modular Curriculum, Drug Saf, vol.37, pp.743-759, 2014.

D. N. Bateman, G. L. Sanders, and M. D. Rawlins, Attitudes to adverse drug reaction reporting in the Northern Region, Br J Clin Pharmacol, vol.34, pp.421-427, 1992.

K. A. Agu, A. C. Oparah, and U. M. Ochei, Improving Monitoring and Reporting of Adverse Drug Reactions (ADRs) in HIV positive patients on Antiretroviral Therapy (ART) in Nigeria, J basic Clin Pharm, vol.3, pp.299-313, 2012.

M. Eccles, J. Grimshaw, and M. Campbell, Research designs for studies evaluating the effectiveness of change and improvement strategies, Qual Saf Heal Care, vol.12, pp.47-52, 2003.

R. Grol and J. Grimshaw, From best evidence to best practice: Effective implementation of change in patients' care, Lancet, vol.362, pp.1225-1230, 2003.

F. Mirbaha, G. Shalviri, and B. Yazdizadeh, Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach, Implement Sci, vol.10, p.110, 2015.

R. Varallo, F. Planeta, C. S. De, and P. , Effectiveness of pharmacovigilance: multifaceted edu-cational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff, Clincal Sci, vol.72, pp.51-57, 2017.

E. Vierron and B. Giraudeau, Design effect in multicenter studies: gain or loss of power, BMC Med Res Methodol, vol.9, p.39, 2009.

K. A. Kannisto, M. H. Koivunen, and M. A. Välimäki, Use of mobile phone text message reminders in health care services: a narrative literature review, J Med Internet Res, vol.16, p.222, 2014.

M. Keogh-brown, M. O. Bachmann, and L. Shepstone, Contamination in trials of educational interventions, Health Technol Assess (Rockv, p.11

B. R. Kirkwood, S. N. Cousens, and C. G. Victora, Issues in the design and interpretation of studies to evaluate the impact of community-based interventions, Trop Med Int Heal, vol.2, pp.1022-1029, 1997.

J. A. Johnson, Drug-Related Morbidity and Mortality, Arch Intern Med, vol.155, p.1949, 1995.

J. C. Bouvy, D. Bruin, M. L. Koopmanschap, and M. A. , Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies, Drug Saf, vol.38, pp.437-453, 2015.

A. Breckenridge, The burden of adverse drug events, Br J Clin Pharmacol, vol.80, pp.785-787, 2015.

U. A. Meyer, Pharmacogenetics and adverse drug reactions, Lancet, vol.356, pp.1667-71, 2000.

W. Liu, Pharmacogenomics-Guided Approaches to Avoiding Adverse Drug Reactions, Clin Pharmacol Biopharm, vol.01, pp.1-5, 2012.

M. Lindquist, Data Quality Management in Pharmacovigilance, Drug Saf, vol.27, pp.857-870, 2004.

D. Adeloye, C. Basquill, and A. V. Aderemi, An estimate of the prevalence of hypertension in Nigeria, J Hypertens, vol.33, pp.230-242, 2015.

Y. G. Tedla and L. E. Bautista, Drug Side Effect Symptoms and Adherence to Antihypertensive Medication, Am J Hypertens, vol.29, pp.772-779, 2016.
DOI : 10.1093/ajh/hpv185

URL : https://academic.oup.com/ajh/article-pdf/29/6/772/24328711/hpv185.pdf

E. Basch, Systematic collection of patient-reported adverse drug reactions: a path to patient-centred pharmacovigilance, Drug Saf, vol.36, pp.277-285, 2013.

L. Rolfes, F. Van-hunsel, and L. Van-der-linden, The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis, Drug Saf, vol.40, pp.607-614, 2017.

H. A. Saleh, A. Fourrier-réglat, and E. Diogène, Patient-centered pharmacovigilance: A review, Trop J Pharm Res, vol.17, p.179, 2018.

S. Ayinbuomwan and A. Isah, Safety and tolerability profile of Artemisinin-based antimalarial combination therapy in adult patients in Benin city, Nigeria. West Afr J Pharmacol Drug Res, vol.29, pp.25-29, 2014.

A. Salami and I. Katibi, Angiotensin converting Enzyme Inhibitors associated cough a prospective evaluation in hypertensives, Ann Afr Med, vol.4, pp.118-121, 2005.

. .. ????????????????????????????????????????????-???,

A. An and . Can, Multiple options can be ticked) a. Result from the pharmacological actions of the drug

, ADR reports should be submitted if the drug is (Multiple options can be ticked) a. A newly marketed medicine Yes

, An established medicine and vaccine Yes

, Misused or used with error Yes

, ADRs should be reported only if they are: (Multiple options can be ticked) a. New Yes

, Who should report an ADR? (Multiple options can be ticked) a. Medical doctors Yes

, Are you aware of the existence of south-south zonal pharmacovigilance centre? Yes

, ???????????? 10. Are you aware that the Nigerian National Pharmacovigilance Centre has edited an ADR reporting form (yellow form) for reporting ADRs? Yes

, What are the important elements in the ADR reporting form (yellow form) in reporting an ADR, vol.12

. Sometiimes, If yes, Why? List the most likely reasons

. .. ,

, Do you feel you should report all ADRS even when you are not sure it is drug related? Yes

, think ADRs reporting should be made mandatory for all health care workers in Nigeria? Yes

A. O. Opadeyi, A. Fourrier-reglat, and A. O. Isah, Drug utilisation pattern in South-South Nigeria using the WHO Core drug prescribing indicators, 2018.

A. O. Opadeyi, A. Fourrier-reglat, A. O. Isah, and . Knowledge, Attitude and Practice of health professionals regarding Pharmacovigilance in South-South Nigeria. Submitted to Pharmacoepidemiology and Drug Safety, 2018.

A. O. Opadeyi, A. Fourrier-reglat, and A. O. Isah, Educational intervention to improve the knowledge, attitude and practice of Health Care Professionals regarding pharmacovigilance in South-South Nigeria. Submitted to Therapeutic Advances in Drug Safety, 2018.

A. O. Opadeyi, A. Fourrier-reglat, and A. O. Isah, Impact of an educational intervention on adverse drug reaction reporting in tertiary hospitals in SouthSouth Nigeria. Submitted to Expert Opinion on Drug Safety, 2018.

A. O. Isah and A. Olowofela, Clinical Pharmacology in Nigeria: the BeninCity experience, Pharmacology Matters, vol.7, issue.2, pp.11-12, 2014.

A. Olowofela and A. O. Isah, Self-reported physical activity levels in hypertensive patients attending the medical out-patient clinic of the University of Benin Teaching Hospital, West African Journal of Pharmacology and Drug Research, vol.29, pp.30-36, 2014.

A. Olowofela and A. O. Isah, A Profile of Adverse Effects of Antihypertensive Medicines in a Tertiary Care Clinic in Nigeria, Annals of African Medicine, vol.16, issue.3, pp.114-119, 2017.

A. Olowofela, S. A. Ayinbuomwan, and A. O. Isah, Sources of information on the use of medicines utilized by resident doctors in a tertiary health care facility in Nigeria, Highland Medical Research Journal, vol.17, issue.2, pp.81-85, 2017.

A. Olowofela, S. A. Ayinbuomwan, and A. O. Isah, The internet as a source of drug information: A profile of utilization by junior hospital doctors in a Nigerian teaching hospital, Annals of Biomedical Science, vol.16, issue.2, pp.226-233, 2017.

A. Olowofela and A. O. Isah, Dietary habits of hypertensive patients in a tertiary hypertension clinic in southern Nigeria, Journal of Medicine and Biomedical Research, vol.15, issue.2, pp.23-33, 2016.

A. Olowofela and A. O. Isah, Antihypertensive medicines prescriptions before and after the Nigeria Hypertension Society guidelines and prescriber's awareness of the guideline, Nigerian Medical Journal, vol.58, issue.3, pp.107-113, 2017.

S. A. Ayinbuomwan, A. Opadeyi, and A. O. Isah, Management of snakebite victims using low dose antisnake venom in a tertiary hospital in Southern Nigeria: A 5-year retrospective study, Research Journal of Health Sciences, vol.6, issue.2, pp.82-89, 2018.

A. Olowofela and A. O. Isah, Medication use practices and inspection of returned pills during follow up attendance at a tertiary care hypertension clinic in Nigeria, Sahel Medical Journal, vol.21, pp.128-164, 2018.